Eli Lilly and Co (LLY) News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks

Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting PR...

Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium

Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products

Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New...

US Futures Rise as Tech Earnings Drive Market Optimism; Oil Prices Edge Up

U.S. index futures rose slightly in Wednesday’s pre-market as traders assessed Alphabet (NASDAQ:GOOGL)’s...

Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study

Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease...

Lilly declares fourth-quarter 2024 dividend

Lilly declares fourth-quarter 2024 dividend PR Newswire INDIANAPOLIS, Oct. 28, 2024 INDIANAPOLIS, Oct. 28...